Graydon Beatty

CSO  Co-founder

Dr. Beatty has over 35 years of experience in the design and development of innovative products for the field of cardiac electrophysiology, including 3D cardiac mapping, intracardiac catheter navigation, and catheter ablation therapies. Dr. Beatty is a world-leading scientific partner with leading physicians worldwide and is considered an expert in the electrical properties of excitable tissue and the biophysics of ablation energy delivery.

Prior to EnChannel Medical as CSO, Dr. Beatty served as Acutus Medical’s Chief Technology Officer (IPO 2020), and prior to Acutus was co-founder and Chief Technical Officer of Endocardial Solutions, Inc. (acquired by St. Jude Medical and Abbott Laboratories). Graydon also held other development and management roles with Cardiac Pacemakers, Inc. (later Guidant and now Boston Scientific), Angemed Corporation (Boston Scientific), EP Technologies (Boston Scientific), and the Electrophysiology division of C.R. Bard (Boston Scientific).

Dr. Beatty holds a BS degree in Electrical Engineering and MS and PhD degrees in Biomedical Engineering from the Universities of Minnesota and Wisconsin. Dr. Beatty has co-authored more than 65 issued U.S. patents in various medical technology fields.